Lili Mao

4PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 24, 2026
LM103, an autologous tumor-infiltrating lymphocyte monotherapy, in patients with advanced melanoma resistant to standard therapy.

|May 02, 2024
Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications.

Jie Dai, Jia Jia, Fanshuang Zhang

|Aug 31, 2022
Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study.

Lili Mao, Meiyu Fang, Yu Chen

|Jan 14, 2021
Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma.

Xieqiao Yan, Xinan Sheng, Zhihong Chi

Pageof 1

Frequent Collaborators

4 joint publications

Jun Guo

3 joint publications

Lu Si

2 joint publications

Yan Kong

1 joint publications

Xieqiao Yan